Harry works primarily in the chemical field with technologies such as semiconductor manufacture, formulations for site specific drug delivery, gas separation and medical devices. He is involved with the preparation, filing and prosecution of patent applications at both the UK Intellectual Property Office and the European Patent Office.
Harry is currently training with Beck Greener to qualify as a British and European Patent Attorney. He recently achieved a distinction in his Certificate in Intellectual Property Law from Bournemouth University.
Qualifications and memberships
- Cert. IP, Bournemouth University 2020
- PhD, Homogeneous Catalysis, University of Bristol 2018
- MChem, Chemistry, University of Liverpool 2014
- Student member of the Chartered Institute of Patent Attorneys (CIPA)
- Student member of the Institute of Professional Representatives before the European Patent Office (epi)
Before joining Beck Greener in 2019, Harry completed a PhD where he developed new synthetic methodologies and elucidated reaction mechanisms of iron-catalysed cross-coupling reactions. He then took up a post-doctoral position, where he focused on the synthesis and application of novel organometallic palladium pre-catalysts.
During his academic career, Harry co-authored five publications in the field of chemistry. With his colleagues James Stones, Anna Hatt and Sarah-Jane, Harry has published two articles relating to pharmaceutical patents.
O’Brien, H. M. & Hatt, A. L. & Stones, J. A., (2021) “Brexit – The Consequences for Pharmaceutical Patents and Supplementary Protection Certificates”, British Journal of Pharmacy 6(1).
Crawford, S. & O’Brien, H. M. & Stones, J. A., (2021) “Case Law: A Review of selected Pharmaceutical Patents in the UK Courts during 2020”, British Journal of Pharmacy 6(1).